Henk W. Berendse
#161,197
Most Influential Person Now
Henk W. Berendse's AcademicInfluence.com Rankings
Henk W. Berendsebiology Degrees
Biology
#12784
World Rank
#16283
Historical Rank
Neuroscience
#2168
World Rank
#2229
Historical Rank

Download Badge
Biology
Henk W. Berendse's Degrees
- Doctorate Medicine University of Amsterdam
Why Is Henk W. Berendse Influential?
(Suggest an Edit or Addition)Henk W. Berendse's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Graph theoretical analysis of magnetoencephalographic functional connectivity in Alzheimer's disease. (2009) (845)
- Topographical organization and relationship with ventral striatal compartments of prefrontal corticostriatal projections in the rat (1992) (834)
- Idiopathic hyposmia as a preclinical sign of Parkinson's disease (2004) (717)
- Organization of the thalamostriatal projections in the rat, with special emphasis on the ventral striatum (1990) (569)
- The specificity of the ‘nonspecific’ midline and intralaminar thalamic nuclei (1994) (528)
- The anatomical relationship of the prefrontal cortex with the striatopallidal system, the thalamus and the amygdala: evidence for a parallel organization. (1990) (525)
- Restricted cortical termination fields of the midline and intralaminar thalamic nuclei in the rat (1991) (501)
- The application of graph theoretical analysis to complex networks in the brain (2007) (481)
- Organization of the output of the ventral striatopallidal system in the rat: Ventral pallidal efferents (1993) (433)
- Frequency-dependent functional connectivity within resting-state networks: An atlas-based MEG beamformer solution (2012) (369)
- Prevalence of smell loss in Parkinson's disease--a multicenter study. (2009) (344)
- Magnetoencephalographic evaluation of resting-state functional connectivity in Alzheimer's disease (2006) (304)
- Connections of the subthalamic nucleus with ventral striatopallidal parts of the basal ganglia in the rat (1990) (301)
- Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell (2001) (292)
- Excessive burden of lysosomal storage disorder gene variants in Parkinson’s disease (2017) (278)
- A Two-Stage Meta-Analysis Identifies Several New Loci for Parkinson's Disease (2011) (278)
- Loss of olfaction in de novo and treated Parkinson's disease: Possible implications for early diagnosis (2001) (264)
- Generalized Synchronization of MEG Recordings in Alzheimer’s Disease: Evidence for Involvement of the Gamma Band (2002) (257)
- Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia. (2007) (245)
- Disrupted brain network topology in Parkinson's disease: a longitudinal magnetoencephalography study. (2014) (214)
- Increased cortico-cortical functional connectivity in early-stage Parkinson's disease: An MEG study (2008) (184)
- Genome-wide association study confirms extant PD risk loci among the Dutch (2011) (175)
- Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease (2016) (174)
- Resting state oscillatory brain dynamics in Parkinson’s disease: An MEG study (2006) (163)
- Magnetoencephalographic analysis of cortical activity in Alzheimer's disease: a pilot study (2000) (154)
- [Impulse control disorders in Parkinson's disease]. (2011) (151)
- Efficacy of community-based physiotherapy networks for patients with Parkinson's disease: a cluster-randomised trial (2010) (147)
- Cognitive decline in Parkinson's disease is associated with slowing of resting-state brain activity: a longitudinal study (2013) (132)
- Functional connectivity and cognitive decline over 3 years in Parkinson disease (2014) (127)
- Hyposmia and executive dysfunction as predictors of future Parkinson's disease: A prospective study (2009) (125)
- Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus (2013) (117)
- The effect of rhythmic somatosensory cueing on gait in patients with Parkinson's disease (2006) (115)
- A comparative study of odor identification and odor discrimination deficits in Parkinson's disease (2008) (113)
- Stage‐dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease (2014) (112)
- Depressive symptoms in Parkinson's disease are related to decreased hippocampus and amygdala volume (2015) (107)
- Olfactory testing combined with dopamine transporter imaging as a method to detect prodromal Parkinson's disease (2009) (106)
- Motor and non-motor correlates of olfactory dysfunction in Parkinson's disease (2011) (105)
- Reduced dopamine transporter binding predates impulse control disorders in Parkinson's disease (2014) (99)
- Distribution and Load of Amyloid-&bgr; Pathology in Parkinson Disease and Dementia with Lewy Bodies (2016) (97)
- Frontal–striatal abnormalities underlying behaviours in the compulsive–impulsive spectrum (2010) (94)
- Anatomical Relationships Between the Prefrontal Cortex and the Basal Ganglia in the Rat (1994) (89)
- The pedunculopontine nucleus is related to visual hallucinations in Parkinson’s disease: preliminary results of a voxel-based morphometry study (2011) (87)
- Emerging roles of microglial activation and non-motor symptoms in Parkinson's disease (2012) (87)
- Depression and impulse control disorders in Parkinson's disease: Two sides of the same coin? (2014) (86)
- Preclinical (premotor) Parkinson’s disease (2000) (85)
- Discovery and functional prioritization of Parkinson’s disease candidate genes from large-scale whole exome sequencing (2017) (85)
- Nuclear origin of thalamic afferents of the ventral striatum determines their relation to patch/matrix configurations in enkephalin-immunoreactivity in the rat. (1988) (83)
- MEG resting state functional connectivity in Parkinson’s disease related dementia (2009) (83)
- Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease (2013) (82)
- CSF α-synuclein does not discriminate dementia with Lewy bodies from Alzheimer's disease. (2010) (81)
- Systematic Review of the Relationship between Vitamin D and Parkinson’s Disease (2016) (79)
- Densitometrical analysis of opioid receptor ligand binding in the human striatum—I. Distribution of μ opioid receptor defines shell and core of the ventral striatum (1996) (77)
- Predicting dementia in Parkinson disease by combining neurophysiologic and cognitive markers (2014) (72)
- Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data (2016) (71)
- The effects of visual rhythms and optic flow on stride patterns of patients with Parkinson's disease. (2006) (71)
- Effects of augmented visual feedback during balance training in Parkinson's disease: a pilot randomized clinical trial. (2014) (70)
- Reduced α‐synuclein levels in cerebrospinal fluid in Parkinson's disease are unrelated to clinical and imaging measures of disease severity (2014) (69)
- Detection of preclinical Parkinson's disease along the olfactory trac(t). (2006) (67)
- Diagnosing premotor Parkinson's disease using a two-step approach combining olfactory testing and DAT SPECT imaging. (2009) (67)
- A neural complexity measure applied to MEG data in Alzheimer's disease (2003) (66)
- Evidence For Two Neurochemical Divisions in the Human Nucleus Accumbens (1994) (66)
- Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: A pathogenetically based approach (2010) (66)
- Resting-state functional connectivity as a marker of disease progression in Parkinson's disease: A longitudinal MEG study☆ (2013) (65)
- Dopaminergic modulation of cortico-cortical functional connectivity in Parkinson's disease: An MEG study (2008) (64)
- Localization of Slow Wave Activity in Patients with Tumor-Associated Epilepsy (2004) (62)
- α‐Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies (2018) (61)
- Anxiety in Parkinson's disease: Symptom dimensions and overlap with depression and autonomic failure. (2015) (58)
- A smaller amygdala is associated with anxiety in Parkinson’s disease: a combined FreeSurfer—VBM study (2015) (58)
- Interventions for fatigue in Parkinson's disease. (2015) (58)
- Reduced neural connectivity but increased task‐related activity during working memory in de novo Parkinson patients (2015) (58)
- The Proteome of the Locus Ceruleus in Parkinson's Disease: Relevance to Pathogenesis (2012) (57)
- Impairment of complex upper limb motor function in de novo Parkinson's disease. (2008) (57)
- Is olfactory impairment in Parkinson disease related to phenotypic or genotypic characteristics? (2008) (57)
- CSF or serum neurofilament light added to α‐Synuclein panel discriminates Parkinson's from controls (2019) (54)
- The Connections of the Medial Part of the Subthalamic Nucleus in the Rat: Evidence for a Parallel Organization (1991) (53)
- Method to measure autonomic control of cardiac function using time interval parameters from impedance cardiography (2008) (52)
- Bright Light Therapy in Parkinson's Disease: An Overview of the Background and Evidence (2012) (52)
- Motor perseveration is an early sign of Parkinson’s disease (2001) (49)
- Signal-to-noise ratio of chemosensory event-related potentials (2007) (48)
- Cortical Thickness, Surface Area and Subcortical Volume Differentially Contribute to Cognitive Heterogeneity in Parkinson’s Disease (2016) (46)
- Compensatory fronto-parietal hyperactivation during set-shifting in unmedicated patients with Parkinson's disease (2015) (46)
- Optimizing odor identification testing as quick and accurate diagnostic tool for Parkinson's disease (2016) (44)
- Pneumocephalus by Valsalva’s maneuver (2003) (42)
- Bimanual coordination dysfunction in early, untreated Parkinson's disease. (2006) (42)
- A three dimensional anatomical view of oscillatory resting-state activity and functional connectivity in Parkinson's disease related dementia: An MEG study using atlas-based beamforming☆ (2012) (41)
- Cholinergic modulation of MEG resting-state oscillatory activity in Parkinson’s disease related dementia (2008) (41)
- Stage-dependent patterns of disturbed neural synchrony in Parkinson's disease. (2007) (41)
- Increased Resting-State Functional Connectivity in Obese Adolescents; A Magnetoencephalographic Pilot Study (2008) (40)
- Pedunculopontine cholinergic cell loss in hallucinating Parkinson disease patients but not in dementia with Lewy bodies patients. (2013) (38)
- Failure of stop and go in de novo Parkinson's disease—a functional magnetic resonance imaging study (2015) (38)
- Patterns of α-synuclein pathology in incidental cases and clinical subtypes of Parkinson's disease. (2012) (36)
- Loss of Functional Connectivity in Patients with Parkinson Disease and Visual Hallucinations. (2017) (36)
- A systematic review of MEG‐based studies in Parkinson's disease: The motor system and beyond (2019) (35)
- Impaired planning in Parkinson's disease is reflected by reduced brain activation and connectivity (2015) (34)
- Organization of the Projections from the Ventral Striato-Pallidal System to Ventral Mesencephalic Dopaminergic Neurons in the Rat (1994) (34)
- The bidirectional longitudinal relationship between insomnia, depression and anxiety in patients with early-stage, medication-naïve Parkinson's disease. (2017) (34)
- Hyposmia as a marker of (non-)motor disease severity in Parkinson’s disease (2019) (33)
- Odour identification and discrimination in Dutch adults over 45 years. (2008) (33)
- Cognitive correlates of visual hallucinations in non-demented Parkinson's disease patients. (2013) (33)
- Analysis of Extrastriatal 123I-FP-CIT Binding Contributes to the Differential Diagnosis of Parkinsonian Diseases (2017) (33)
- Beneficial effect of transcranial magnetic stimulation on sleep in Parkinson's disease (2009) (33)
- Quantification of dopamine transporter binding using [18F]FP-β-CIT and positron emission tomography (2006) (33)
- International Multicenter Analysis of Brain Structure Across Clinical Stages of Parkinson's Disease (2021) (33)
- Heterogeneous distribution of dopamine D1 and D2 receptors in the human ventral striatum (1993) (32)
- Body awareness training in the treatment of wearing-off related anxiety in patients with Parkinson's disease: Results from a pilot randomized controlled trial. (2017) (31)
- Prodromal Markers in Parkinson’s Disease: Limitations in Longitudinal Studies and Lessons Learned (2016) (31)
- Extended testing across, not within, tasks raises diagnostic accuracy of smell testing in Parkinson's disease (2009) (31)
- A Large‐Scale Full GBA1 Gene Screening in Parkinson's Disease in the Netherlands (2020) (31)
- Serotonin transporter binding and anxiety symptoms in Parkinson’s disease (2017) (31)
- Bright light therapy for depression in Parkinson disease (2019) (30)
- Slowing of M1 activity in Parkinson’s disease during rest and movement – An MEG study (2011) (30)
- Early-stage [123I]β-CIT SPECT and long-term clinical follow-up in patients with an initial diagnosis of Parkinson’s disease (2005) (30)
- Management of psychosis in Parkinson's disease (2001) (30)
- Deficits on Corsi's block-tapping task in early stage Parkinson's disease. (2003) (29)
- Early‐stage cognitive impairment in Parkinson’s disease and the influence of dopamine replacement therapy (2012) (29)
- The Effects of Cognitive Training on Brain Network Activity and Connectivity in Aging and Neurodegenerative Diseases: a Systematic Review (2020) (28)
- Cerebrospinal fluid and plasma clusterin levels in Parkinson's disease. (2013) (27)
- Predictors of anxiety in early-stage Parkinson's disease - Results from the first two years of a prospective cohort study. (2017) (26)
- Changes in resting-state directed connectivity in cortico-subcortical networks correlate with cognitive function in Parkinson’s disease (2017) (26)
- Complexity Analysis of Resting-State MEG Activity in Early-Stage Parkinson’s Disease Patients (2011) (24)
- Methods in Neuroepidemiology Characterization of European Longitudinal Cohort Studies in Parkinson's Disease - Report of the JPND Working Group BioLoC-PD (2015) (24)
- Early-onset cortico-cortical synchronization in the hemiparkinsonian rat model. (2015) (24)
- Anxiety in Parkinson's disease is associated with reduced structural covariance of the striatum. (2018) (23)
- Smaller subcortical volume in Parkinson patients with rapid eye movement sleep behavior disorder (2018) (23)
- CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson’s disease: a study in LRRK2 mutation carriers (2020) (22)
- Global and Subnetwork Changes of the Structural Connectome in de novo Parkinson’s Disease (2018) (22)
- Neuropathological correlates of parkinsonian disorders in a large Dutch autopsy series (2020) (22)
- Abnormal susceptibility to distracters hinders perception in early stage Parkinson's disease: a controlled study (2006) (21)
- The Dopamine Stabilizer (−)-OSU6162 Occupies a Subpopulation of Striatal Dopamine D2/D3 Receptors: An [11C]Raclopride PET Study in Healthy Human Subjects (2015) (21)
- Damaged fiber tracts of the nucleus basalis of Meynert in Parkinson’s disease patients with visual hallucinations (2017) (21)
- [Presymptomatic detection of Parkinson's disease]. (2002) (21)
- Differential insular cortex sub-regional atrophy in neurodegenerative diseases: a systematic review and meta-analysis (2019) (21)
- The Basal Ganglia IX (2009) (21)
- Treatment of Fatigue in Parkinson Disease. (2016) (21)
- Novelty processing and memory formation in Parkinson׳s disease (2014) (20)
- Using PROMs during routine medical consultations: The perspectives of people with Parkinson’s disease and their health professionals (2019) (19)
- Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An 123I-FP-CIT SPECT study (2019) (18)
- Alterations in Functional Cortical Hierarchy in Hemiparkinsonian Rats (2017) (17)
- Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies (2016) (16)
- A double-blind randomized controlled trial to assess the effect of bright light therapy on depression in patients with Parkinson’s disease (2016) (16)
- Autonomic failure in Parkinson’s disease is associated with striatal dopamine deficiencies (2020) (16)
- Profiling cognitive and neuropsychiatric heterogeneity in Parkinson's disease. (2016) (16)
- Opioid receptor ligand binding in the human striatum: II. Heterogeneous distribution of kappa opioid receptor labeled with [3H]Bremazocine (1996) (15)
- Flavor perception and the risk of malnutrition in patients with Parkinson’s disease (2018) (15)
- Advanced time‐series analysis of MEG data as a method to explore olfactory function in healthy controls and Parkinson's disease patients (2009) (15)
- Differences in neurology residency training programmes across Europe – a survey among the Residents and Research Fellow Section of the European Academy of Neurology national representatives (2020) (15)
- The ParkinsonNet trial: Design and baseline characteristics (2010) (15)
- Lower 123I-FP-CIT binding to the striatal dopamine transporter, but not to the extrastriatal serotonin transporter, in Parkinson's disease compared with dementia with Lewy bodies (2018) (15)
- Parkinsonism & related disorders. Proceedings of the XVII WFN World Congress on Parkinson's disease and related disorders. (2007) (14)
- Anterior insular network disconnection and cognitive impairment in Parkinson’s disease (2020) (13)
- The Association of Olfactory Function with BMI, Appetite, and Prospective Weight Change in Dutch Community-Dwelling Older Adults (2019) (13)
- Motor effects of deep brain stimulation correlate with increased functional connectivity in Parkinson's disease: An MEG study (2020) (11)
- SERT-to-DAT ratios in early Parkinson’s disease do not correlate with the development of dyskinesias (2013) (11)
- Monitoring therapeutic effects in Parkinson's disease by serial imaging of the nigrostriatal dopaminergic pathway (2011) (11)
- Diplopia in Parkinson’s disease: visual illusion or oculomotor impairment? (2019) (10)
- Odor recognition memory is not independently impaired in Parkinson’s disease (2009) (10)
- In vivo exploration of retinal nerve fiber layer morphology in Parkinson’s disease patients (2018) (10)
- Functional connectivity between resting-state networks reflects decline in executive function in Parkinson’s disease: A longitudinal fMRI study (2020) (10)
- Processing speed is related to striatal dopamine transporter availability in Parkinson's disease (2020) (10)
- The influence of computer experience on visuo-motor control: implications for visuo-motor testing in Parkinson’s disease (2002) (10)
- Gray matter differences contribute to variation in cognitive performance in Parkinson's disease (2014) (9)
- Using time interval parameters from impedance cardiography to evaluate autonomic nervous function in Parkinson’s disease (2007) (9)
- Reduced task-related functional connectivity during a set-shifting task in unmedicated early-stage Parkinson’s disease patients (2016) (9)
- Using the Initial Systolic Time Interval to assess cardiac autonomic nervous function in Parkinson’s disease (2011) (8)
- Contactin-1 Is Reduced in Cerebrospinal Fluid of Parkinson’s Disease Patients and Is Present within Lewy Bodies (2020) (8)
- COGTIPS: a double-blind randomized active controlled trial protocol to study the effect of home-based, online cognitive training on cognition and brain networks in Parkinson’s disease (2019) (8)
- Using genome-Wwide complex trait analysis to quantify 'missing heritability' in Parkinson's disease (2012) (8)
- Disrupted Brain Network Topology in Parkinson's Disease: a Longitudinal Meg Study (2014) (8)
- A 51‐year‐old male CML patient with progressive hearing loss, confusion, ataxia, and aphasia during imatinib treatment (2009) (8)
- CSF Biomarkers Reflecting Protein Pathology and Axonal Degeneration Are Associated with Memory, Attentional, and Executive Functioning in Early-Stage Parkinson′s Disease (2020) (8)
- Structural and functional correlates of subthalamic deep brain stimulation-induced apathy in Parkinson’s disease (2020) (7)
- BEWARE: Body awareness training in the treatment of wearing-off related anxiety in patients with Parkinson’s disease: study protocol for a randomized controlled trial (2015) (6)
- [Parkinson's disease: pathogenesis, aetiology, symptoms, diagnostics, and its course]. (2018) (6)
- Structural network topology and microstructural alterations of the anterior insula associate with cognitive and affective impairment in Parkinson’s disease (2021) (6)
- Differences in neurology residency training programmes across Europe - a survey among EAN-RRFS national representatives. (2020) (6)
- Serotonin Transporter Availability in Early Stage Parkinson's Disease and Multiple System Atrophy (2014) (5)
- Prevalence of Prodromal Symptoms of Parkinson’s Disease in the Late Middle-Aged Population (2022) (5)
- A smaller amygdala is associated with anxiety in Parkinson’s disease – a combined FreeSurfer-Voxel-based-morphometry study (2015) (5)
- Olfactory dysfunction in Parkinson's disease and related disorders (2010) (5)
- An International Multicenter Analysis of Brain Structure across Clinical Stages of Parkinson's Disease: The ENIGMA-Parkinson's Study (2020) (5)
- CHanGes In endolYsosoMal enzYMe aCtIVItIes In CereBrosPInal (2014) (4)
- Observations on the cortical silent period in Parkinson's disease. (2007) (4)
- P2.082 ParkNet: a multifaceted strategy to implement practice guidelines for physiotherapy in Parkinson's disease (2007) (4)
- Visual hallucinations in Parkinson’s disease are associated with thinning of the inner retina (2020) (4)
- [Hypersexuality and other impulse control disorders in Parkinson's disease]. (2016) (4)
- Eight-week multi-domain cognitive training does not impact large-scale resting-state brain networks in Parkinson’s disease (2022) (4)
- Is dopaminergic medication dose associated with self-reported bruxism in Parkinson’s disease? A cross-sectional, questionnaire-based study (2020) (4)
- Salivation in Parkinson's disease: A scoping review. (2022) (4)
- Effect of eight-week online cognitive training in Parkinson's disease: A double-blind, randomized, controlled trial. (2022) (4)
- Longitudinal consistency of source-space spectral power and functional connectivity using different magnetoencephalography recording systems (2021) (3)
- Clinical Applications of [123I]FP-CIT SPECT Imaging (2014) (3)
- Optically nonlinear effects in bulk chiral nematic NLO-polymers: second harmonic generation in chiral nematic polymer films (1995) (3)
- Erratum to: α-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies: CSF α-Synuclein species as biomarkers for DLB (Movement Disorders, (2018), 33, 11, (1724-1733), 10.1002/mds.111) (2019) (3)
- I.4 Early diagnosis in PD: olfaction (2006) (3)
- Discovery and functional prioritization of Parkinson’s disease candidate genes from large-scale whole exome sequencing (2017) (3)
- CSF alpha-synuclein is not diagnostic for dementia with Lewy bodies, but related to cognitive decline (2010) (2)
- 1.106 Are brain networks changed in Parkinson's disease? A graph theoretical analysis of resting-state magneto-encephalographic functional connectivity (2007) (2)
- Balance training with augmented visual feedback in Parkinson’s disease: a randomized clinical trial (2015) (2)
- What you always wanted to know about … Early Markers in PD (2007) (2)
- PL6.4 Selected oral abstract: ParkNet implementation: evaluation of health bene.ts (2008) (2)
- ALPHA-SYNUCLEIN SPECIES AS POTENTIAL CSF BIOMARKERS FOR DEMENTIA WITH LEWY BODIES (2017) (2)
- Using PROMs during routine medical consultations (2019) (2)
- Effect of Eight-Week Online Cognitive Training in Parkinson's Disease: A Randomized Controlled Trial (2021) (2)
- Early stage CIT SPECT and long- term clinical follow-up in patients with an initial clinical diagnosis of Parkinson's disease (2004) (2)
- Clinical and genetic evaluation of 8 Polish families with levodopa-responsive parkinsonism (2005) (2)
- Parkinsonism & Related Disorders (2008) (2)
- Improving the efficiency of physiotherapeutic care in Parkinson's disease: ParkNet trial. (2005) (2)
- 3.405 ParkNet implementation: Evaluation of health benefits (2007) (1)
- P.5.d.005 Reduced dopamine transporter binding predates impulse control disorders in Parkinson's disease (2013) (1)
- V.9 Cognitive dysfunction and dementia in Parkinson's Disease: EEG/MEG experience (2006) (1)
- LOWE 123 IFP-CIT BINDING TO THE STRIA AL DOPAMINE TRANSPORTER , BUT NOT TO TH EXTRASTRIATAL SEROTONIN TRANSPORTER , IN PARKINSON ’ S DISEASE COMPARED WITH DEMENTIA WITH LEWY BODIES 3 (2018) (1)
- [Anxiety, depression and sleep disorders in Parkinson's disease: a complex interaction between body and mind]. (2020) (1)
- Pathological organization of resting-state functional brain networks in Parkinson's disease: A longitudinal MEG graph theoretical analysis (2013) (1)
- Orofacial pain and dysfunction in patients with Parkinson's disease: A scoping review (2022) (1)
- Cognitive Training in Parkinson’s Disease Induces Local, Not Global, Changes in White Matter Microstructure (2021) (1)
- The Effects of Bright Light Therapy on Depression, Sleep and Circadian Rhythm in Patients with Parkinson's Disease and a Depressive Disorder: Results of a Double-Blind Randomized Controlled Trial (2018) (1)
- 3.016 Dopamine dependent changes in resting-state cortico-cortical synchronisation in mild to moderate Parkinson's disease (2007) (1)
- Balance training with augmented visual feedback in Parkinson's disease: a randomized clinical trial (2015) (1)
- Functional connectivity alterations in Parkinson’s disease during the stop-signal task (2018) (1)
- Neuroimaging in movement disorders: PET and SPECT [ch.32] (2007) (1)
- V.10 The neurophysiology of dementia in Parkinson's Disease: does connectivity count? (2006) (1)
- [Pergolide use and heart valve fibrosis. Yearly control in patients with Parkinson disease who use pergolide]. (2009) (1)
- IV.P12 The influence of dopaminomimetics on resting state functional connectivity in Parkinson's Disease: an MEG study (2006) (1)
- Deletions at 22q11.2 in idiopathic Parkinson's disease: A combined analysis of GWAS data (2016) (1)
- [Possible treatment options for Parkinson's disease]. (2019) (1)
- Detection of preclinical Parkinson's disease: the olfactory approach (2004) (1)
- 5th International Conference on Neurology and Epidemiology. Gold Coast, Australia, November 18-20, 2015: Abstracts (2015) (1)
- Comparison of [18F]-FDOPA PET and [123I]-FP-CIT SPECT acquired in clinical practice for assessing nigrostriatal degeneration in patients with a clinically uncertain parkinsonian syndrome (2022) (0)
- LONGITUDINAL DECREASES IN FUNCTIONAL CONNECTIVITY AND COGNITIVE DECLINE IN PARKINSON’S DISEASE (2014) (0)
- Reply (2005) (0)
- Parkinson’s disease, temporomandibular disorder pain and bruxism and its clinical consequences: a protocol of a single-centre observational outpatient study (2022) (0)
- Chapter 7 Interventions for fatigue in Parkinson ’ s disease : a Cochrane Review (2015) (0)
- Corrigendum to “Structural and functional correlates of deep brain stimulation-induced apathy in Parkinson's disease” (2022) (0)
- 1.111 Impaired odour recognition memory in Parkinson's disease (2007) (0)
- Reply: Olfaction and early detection of Parkinson's disease (2005) (0)
- PET and SPECT imaging in movement disorders (2006) (0)
- An Unusual Dystonic Manifestation in Wilson's Disease (2018) (0)
- I.P15 The predictive value of olfactory dysfunction and cognitive dysfunction for preclinical Parkinson's Disease (2006) (0)
- IC-P1-015: Random brain networks in Alzheimer's disease (2008) (0)
- Distance to white matter tracts predicts STN deep brain stimulation outcome of tremor and dysarthria in Parkinson's disease (2018) (0)
- Proteomic Analysis of the Locus Ceruleus in Parkinson's Disease (2010) (0)
- The Loss of Extrastriatal As Well As Striatal [I-123]FP-CIT Binding Is More Pronounced in MSA-P and PSP Than in Parkinson's Disease (2016) (0)
- Smaller subcortical volume in Parkinson patients with rapid eye movement sleep behavior disorder (2018) (0)
- Cognitive decline relates to reversal of information flow in cortico-subcortical networks in the Parkinson's disease brain (2017) (0)
- Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease (2016) (0)
- The Effects of Cognitive Training on Brain Network Activity and Connectivity in Aging and Neurodegenerative Diseases: a Systematic Review (2020) (0)
- 2.031 NEUROPHYSIOLOGICAL CORRELATES OF COGNITIVE DECLINE IN PARKINSON'S DISEASE: A LONGITUDINAL MAGNETOENCEPHALOGRAPHIC STUDY (2012) (0)
- Chapter 3 Reduced task-related functional connectivity during a set-shifting task in unmedicated Parkinson ’ s disease patients (2015) (0)
- Parkinson's disease and oral health: A systematic review. (2023) (0)
- Nigral pathology contributes to microstructural integrity of striatal and frontal tracts in Parkinson’s disease (2022) (0)
- noVel BIoMarKer CandIdates (2014) (0)
- IdentIFICatIon oF noVel BIoMarKer CandIdates In tHe CereBrosPInal FluId ProteoMe oF druG-naïVe ParKInson’s dIsease PatIents (2014) (0)
- The neurology of olfaction (2009) (0)
- 1.112 Olfactory dysfunction in Parkinson's disease: Is extended testing useful to discriminate between patients and controls? (2007) (0)
- Proceedings of the XVII WFN World Congress on Parkinson's Disease and Related Disorders, Amsterdam, 9-13 December 2007: Preface (2007) (0)
- The confounding effect of computer-experience in the interpretation of computerised visuomotor testing (1999) (0)
- Early-stage [I]β-CIT SPECT and long-term clinical follow-up in patients with an initial diagnosis of Parkinson’s disease (2005) (0)
- Author response for "Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow‐up" (2021) (0)
- TV‐L1 Ordinal Logistic Regression Reveals New Morphometric Patterns Related to Parkinsonian Symptom Severity: An ENIGMA‐PD study (2022) (0)
- Volume contents (1994) (0)
- TUO08 Cholinergic modulation of MEG resting state oscillatory activity in Parkinson's disease related dementia (2008) (0)
- 1.113 Hyposmia, cognitive dysfunction and the future risk of Parkinson's disease: A five-year prospective study (2007) (0)
- 2.131 CSF CLUSTERIN IS ASSOCIATED WITH COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE BIOMARKERS IN PARKINSON'S DISEASE PATIENTS (2012) (0)
- The effects of dopamine on memory formation in Parkinson's patients (2012) (0)
- Reduced task-related functional connectivity during a set-shifting task in unmedicated early-stage Parkinson’s disease patients (2016) (0)
- Cortical and Subcortical Changes in MEG Activity Reflect Parkinson's Progression Over a Period of 7 Years (2022) (0)
- The article by Ponsen and colleagues 1 and the accompanying editorial by Stern 2 point out the importance of preclinical detection of risk for subsequent development of Parkinson's (2004) (0)
- 15.18 Improving the efficiency of physiotherapeutic care in Parkinson's disease: the PARKNET trial (2005) (0)
- Contents Vol. 45, 2015 (2015) (0)
- Neuropathological correlates of parkinsonian disorders in a large Dutch autopsy series (2020) (0)
- P1-243 ALPHA-SYNUCLEIN SPECIES AS POTENTIAL CSF BIOMARKERS FOR DEMENTIAWITH LEWY BODIES (2017) (0)
- P2.086 A process evaluation of ParkNet implementation (2007) (0)
- 3.101 Functional connectivity in Parkinson's disease related dementia: A MEG study (2007) (0)
- Olfaction and warly detection of Parkinson's disease. Authors' reply (2005) (0)
- Differential insular cortex sub-regional atrophy in neurodegenerative diseases: a systematic review and meta-analysis (2019) (0)
- Nucleus in the Hemiparkinsonian Rat With Deep Brain Stimulation of the Subthalamic The Electrocorticogram Signal Can Be Modulated (2015) (0)
- Damaged fiber tracts of the nucleus basalis of Meynert in Parkinson’s disease patients with visual hallucinations (2017) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Henk W. Berendse?
Henk W. Berendse is affiliated with the following schools: